Qingdao Baheal Medical Inc
SZSE:301015
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Qingdao Baheal Medical Inc
Other Receivables
Qingdao Baheal Medical Inc
Other Receivables Peer Comparison
1099
601607
600998
000963
Competitive Other Receivables Analysis
Latest Figures & CAGR of Competitors
| Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
Q
|
Qingdao Baheal Medical Inc
SZSE:301015
|
Other Receivables
¥321.9m
|
CAGR 3-Years
32%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Other Receivables
¥11.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Other Receivables
¥9B
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
15%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Other Receivables
¥9.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Other Receivables
¥4.3B
|
CAGR 3-Years
65%
|
CAGR 5-Years
35%
|
CAGR 10-Years
38%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Other Receivables
¥1.8B
|
CAGR 3-Years
36%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
See Also
What is Qingdao Baheal Medical Inc's Other Receivables?
Other Receivables
321.9m
CNY
Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Other Receivables amounts to 321.9m CNY.
What is Qingdao Baheal Medical Inc's Other Receivables growth rate?
Other Receivables CAGR 5Y
35%
Over the last year, the Other Receivables growth was 25%. The average annual Other Receivables growth rates for Qingdao Baheal Medical Inc have been 32% over the past three years , 35% over the past five years .
You don't have any saved screeners yet
